Panax Ginseng
Last updated on December 22, 2020 Cognitive Vitality Reports® are reports written by neuroscientists at the Alzheimer’s Drug Discovery Foundation (ADDF). These scientific reports include analysis of drugs, drugs-in- development, drug targets, supplements, nutraceuticals, food/drink, non-pharmacologic interventions, and risk factors. Neuroscientists evaluate the potential benefit (or harm) for brain health, as well as for age-related health concerns that can affect brain health (e.g., cardiovascular diseases, cancers, diabetes/metabolic syndrome). In addition, these reports include evaluation of safety data, from clinical trials if available, and from preclinical models. Panax Ginseng Evidence Summary Some studies have shown that ginseng improves cognitive functions and decreases mortality and cancer risk in humans; safe when taken alone, but some drug interactions are known. Neuroprotective Benefit: Numerous studies have reported cognitive benefit with ginseng in healthy people as well as in dementia patients, but the evidence remains inconclusive due to the lack of large, long-term well-designed trials. Aging and related health concerns: Ginseng intake is associated with lower risks for mortality and cancers; also, some benefits seen in Asian people with ischemic heart disease, diabetes, hypertension, hypercholesteremia, and fatigue. Safety: Numerous meta-analyses have reported that ginseng is generally safe when taken alone; however, ginseng interacts with several medications, and high doses may be associated with insomnia, tachyarrhythmias, hypertension, nervousness, and others. 1 Last updated on December 22, 2020 Availability: OTC. In clinical Dose: 200-400 mg/day Chemical formula: e.g., C42H72O14 trials, a standardized ginseng have been tested for (Ginsenoside Rg1); C54H92O23 extract called G115 is often cognitive benefit; higher (Ginsenoside Rb1) used.
[Show full text]